| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/07/2007 | US7253341 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/07/2007 | US7253273 Polynucleotide encoding a protein comprising an engineered zinc finger DNA-binding domain |
| 08/07/2007 | US7253272 Gene BRCC-2 and diagnostic and therapeutic uses thereof |
| 08/07/2007 | US7253269 Useful as an ingredient for remedies for various diseases accompanied with cell death since it effectively inhibit cell death such as apoptosis |
| 08/07/2007 | US7253267 preferred sites for substitution are the N- and O-linked glycosylation sites |
| 08/07/2007 | US7253266 Polypeptides of FGF-CX |
| 08/07/2007 | US7253265 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 08/07/2007 | US7253264 Polypeptide for use in the diagnosis and treatment of blood, kidney and liver disoders |
| 08/07/2007 | US7253262 Dried blood factor composition comprising trehalose |
| 08/07/2007 | US7253259 Protein containing serum albumin domain |
| 08/07/2007 | US7253256 Polypeptides encoded by a nucleic acid are expressed in esophageal and kidney tumor |
| 08/07/2007 | US7253255 Polypeptide encoded by a nucleic acid underexpressed in esophageal tumor and melanoma |
| 08/07/2007 | US7253254 Polypeptide variants with increased heparin-binding capacity |
| 08/07/2007 | US7253207 Quinones as disease therapies |
| 08/07/2007 | US7253160 Depeptidized inhibitors of hepatitis C virus NS3 protease |
| 08/07/2007 | US7253159 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7253150 Gene delivery vehicle expressing the aptosis-inducing proteins VP2 and/or apoptin |
| 08/07/2007 | US7253149 Compounds and methods for modulating cell-adhesion mediated drug resistance |
| 08/07/2007 | US7253148 Human protein, P1h, can be used for immunosuppressive actions and clinical applications for proliferative disorders; suppressing immune response; identifying altered expression of the human gene, particularly in blood cells obtained from a patient diagnosed with lupus |
| 08/07/2007 | US7253147 Gentically engineered serum albumin comprising three-amino acid truncation at its n-terminal and decreased receptivity for trace metals for use in cosmetic and pharmaceutical preparations |
| 08/07/2007 | US7253146 Biopolymer compounds for prevention and treatment of cell proliferative, respiratory system, viral and microbial disorders; antitumor/antiprolifefrative agents; disenfectants |
| 08/07/2007 | US7253144 Method for producing by cell-free protein synthesis system using thioredoxin-fused protein expression vector |
| 08/07/2007 | US7253143 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide |
| 08/07/2007 | US7253142 Protein solution preparation and method of stabilizing the same |
| 08/07/2007 | US7252998 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 08/07/2007 | US7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 08/07/2007 | US7252996 Ancillary composition for the preparation of committed mature dentritic cells |
| 08/07/2007 | US7252989 A replicated and packaged vector construct inside a virion particle in the helper cell, able expressing a foreign gene in a mammalian cell; use in transfection |
| 08/07/2007 | US7252974 Human growth gene and short stature gene region |
| 08/07/2007 | US7252973 Protein and processes for producing the same |
| 08/07/2007 | US7252970 Glutamate transporter associated proteins and methods of use thereof |
| 08/07/2007 | US7252969 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 08/07/2007 | US7252968 Deregulated chromatin-regulator genes that have a SET domain encoding specific proteins having a stop codon that shortens the protein by 47 C-terminal amino acids; for use in diagnosis and therapy of cancer |
| 08/07/2007 | US7252967 Nucleic acids encoding cytokine-like proteins that promote cell proliferation |
| 08/07/2007 | US7252963 β-secretase enzyme compositions and methods |
| 08/07/2007 | US7252956 Antibodies to human Ependymin |
| 08/07/2007 | US7252929 Methods for identifying alpha PDGFR agonists and antagonists |
| 08/07/2007 | US7252829 HLA binding peptides and their uses |
| 08/07/2007 | US7252827 Fusion protein comprising an immunogenic polypeptide; treatment of Hepatitis CVirus infection and assays for the diagnosis of HCV |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | US7252824 Anti-neovasculature preparations for cancer |
| 08/07/2007 | US7252823 Recombinant A2-specific TNFα-specific antibodies |
| 08/07/2007 | US7252820 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof |
| 08/07/2007 | US7252818 Revascularizing ischemic region using genetically engineered potent regulator of cell development; treatment of cardiovascular disorders; myocardial vascularization |
| 08/07/2007 | US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 08/07/2007 | US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | US7252597 Golf club assembly with recessed adjuster assembly |
| 08/07/2007 | CA2424242C Methods for treating muscle injuries |
| 08/07/2007 | CA2407952C Growth factor modified protein matrices for tissue engineering |
| 08/07/2007 | CA2381770C Human ctla-4 antibodies and their uses |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2373252C Long lasting anti-angiogenic peptides |
| 08/07/2007 | CA2369810C Method of treating pain |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2325842C Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 08/07/2007 | CA2301799C Novel conjugates of opioids and endogenous carriers |
| 08/07/2007 | CA2292953C High-activity phytase granulate |
| 08/07/2007 | CA2289196C Sustained-release delayed gels |
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2252374C A process for viral inactivation of lyophilized blood proteins |
| 08/07/2007 | CA2246378C Isolation and use of sh3 binding peptides |
| 08/07/2007 | CA2239702C Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/07/2007 | CA2163112C A coagulation factor viii formulation |
| 08/07/2007 | CA2151563C Preparation of stable zinc insulin analog crystals |
| 08/07/2007 | CA2124801C Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 08/07/2007 | CA2115565C Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 08/07/2007 | CA2092718C Use of protective agents against reactive oxygen species |
| 08/02/2007 | WO2007087637A2 Compositions and methods using matrix metalloproteinase (mmp) inhibitors for treating cognitive impairment characterized by persistent or sustained mmp expression and/or activity |
| 08/02/2007 | WO2007087577A2 Drug delivery system for retarding release of water soluble drugs |
| 08/02/2007 | WO2007087572A2 Aza-peptide epoxides |
| 08/02/2007 | WO2007087524A2 Treatment of acute respiratory distress syndrome |
| 08/02/2007 | WO2007087468A2 Adiponectin for treatment of various disorders |
| 08/02/2007 | WO2007087428A2 Thrombopoietic compounds |
| 08/02/2007 | WO2007087367A2 Methods and compositions for modulating the mobilization of stem cells |
| 08/02/2007 | WO2007087241A2 Treatment of ischemic disease using thrombopoietin |
| 08/02/2007 | WO2007087154A2 Methods for enhancing therapeutic effects of a neurotoxin |
| 08/02/2007 | WO2007087053A2 Bmp-7 variant compositions, methods and uses |
| 08/02/2007 | WO2007086932A2 Prostate stem cell antigen vaccines and uses thereof |
| 08/02/2007 | WO2007086637A1 Mass producing method of growth factor using adipose derived adult stem cells |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007085887A1 Pyy agonists and uses thereof |
| 08/02/2007 | WO2007085879A1 Compositions containing substances obtained from the blood and other biological fluid of snake : methods for their preparation and their use |
| 08/02/2007 | WO2007085728A2 Composition containing several botulic toxins |
| 08/02/2007 | WO2007085626A1 Purification and use of a factor for supporting wound healing |
| 08/02/2007 | WO2007085456A1 Asparagine-10-substituted nonadepsipeptides |
| 08/02/2007 | WO2007085453A1 Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis |
| 08/02/2007 | WO2007085412A1 Fgf2-binding peptides and uses thereof |
| 08/02/2007 | WO2007085087A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2007085057A1 A medical protocol |
| 08/02/2007 | WO2007065437A3 Modulation of the p2y2 receptor pathway |
| 08/02/2007 | WO2007061924A3 Methods of treating cartilage defects |
| 08/02/2007 | WO2007055743A3 Treatment of obesity and related disorders |
| 08/02/2007 | WO2007054151A3 Use of chorionic gonadotropin as an immunosuppressor |
| 08/02/2007 | WO2007052067A3 Von willebrand factor (vwf) binding peptides |
| 08/02/2007 | WO2007050043A3 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 08/02/2007 | WO2007047874A3 Recombinantly modified plasmin |